Details for New Drug Application (NDA): 008983
✉ Email this page to a colleague
NDA 008983 describes ARFONAD, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the ARFONAD profile page.
The generic ingredient in ARFONAD is trimethaphan camsylate. There is one drug master file entry for this compound. Additional details are available on the trimethaphan camsylate profile page.
The generic ingredient in ARFONAD is trimethaphan camsylate. There is one drug master file entry for this compound. Additional details are available on the trimethaphan camsylate profile page.
Summary for 008983
| Tradename: | ARFONAD |
| Applicant: | Roche |
| Ingredient: | trimethaphan camsylate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 008983
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
